GlassScriptPhysician profile
Vu D Nguyen
NPI 1093755357
$3,327.38
in general payments reported to CMS, 2019-2025
19 companies · $564 in 2025
The $564 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $646 · 2020: $326 · 2021: $229 · 2022: $526 · 2023: $639 · 2024: $397 · 2025: $564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,600.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $888.78 | 2019-2024 | Ffrct |
| Abbott Laboratories | $691.59 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $301.40 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $204.92 | 2023-2025 | Camzyos, Eliquis |
| Impulse Dynamics (USA) INC. | $185.00 | 2023 | Optimizer |
| Bayer Healthcare Pharmaceuticals INC. | $173.79 | 2025 | |
| Bolton Medical INC | $148.60 | 2025 | Treo Abdominal Stent-Graft System |
| Atricure, INC. | $146.70 | 2023 | |
| Cvrx, INC. | $133.03 | 2022 | |
| Edwards Lifesciences Corporation | $98.16 | 2022 | |
| Novo Nordisk INC | $79.01 | 2022 | |
| Boston Scientific Corporation | $63.72 | 2019-2022 | |
| Abiomed | $42.66 | 2024 | Impella |
| Inspire Medical Systems, INC. | $38.22 | 2024-2025 | Inspire |
| Pfizer INC. | $37.17 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $34.81 | 2019 | |
| Janssen Pharmaceuticals, INC | $28.55 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $19.87 | 2019 | |
| Tactile Systems Technology INC | $11.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vu Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.